These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The cardiovascular and autonomic effects of repeated administration of delta-9-tetrahydrocannabinol to rhesus monkeys. Fredericks AB; Benowitz NL; Savanapridi CY J Pharmacol Exp Ther; 1981 Feb; 216(2):247-53. PubMed ID: 6257883 [TBL] [Abstract][Full Text] [Related]
7. Interactions between delta 9-tetrahydrocannabinol and cannabidiol as evaluated by drug discrimination procedures in rats and pigeons. Hiltunen AJ; Järbe TU Neuropharmacology; 1986 Feb; 25(2):133-42. PubMed ID: 3010159 [TBL] [Abstract][Full Text] [Related]
9. The pharmacokinetics and the pharmacodynamics of cannabinoids. Lucas CJ; Galettis P; Schneider J Br J Clin Pharmacol; 2018 Nov; 84(11):2477-2482. PubMed ID: 30001569 [TBL] [Abstract][Full Text] [Related]
10. Behaviour in rats maintained by low differential reinforcement rate: effects of delta 1-tetrahydrocannabinol, cannabinol and cannabidiol, alone and in combination. Hiltunen AJ; Järbe TU; Kamkar MR; Archer T Neuropharmacology; 1989 Feb; 28(2):183-9. PubMed ID: 2541367 [TBL] [Abstract][Full Text] [Related]
11. Prolonged delta-9-tetrahydrocannabinol ingestion. Effects of sympathomimetic amines and autonomic blockades. Benowitz NL; Jones RT Clin Pharmacol Ther; 1977 Mar; 21(3):336-42. PubMed ID: 837652 [TBL] [Abstract][Full Text] [Related]
12. Effects of marihuana cannabinoids on seizure activity in cobalt-epileptic rats. Colasanti BK; Lindamood C; Craig CR Pharmacol Biochem Behav; 1982 Apr; 16(4):573-8. PubMed ID: 6280204 [TBL] [Abstract][Full Text] [Related]
13. A randomised controlled trial of vaporised Δ Solowij N; Broyd S; Greenwood LM; van Hell H; Martelozzo D; Rueb K; Todd J; Liu Z; Galettis P; Martin J; Murray R; Jones A; Michie PT; Croft R Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):17-35. PubMed ID: 30661105 [TBL] [Abstract][Full Text] [Related]
14. Neuropsychiatric and General Interactions of Natural and Synthetic Cannabinoids with Drugs of Abuse and Medicines. Arellano AL; Papaseit E; Romaguera A; Torrens M; Farré M CNS Neurol Disord Drug Targets; 2017; 16(5):554-566. PubMed ID: 28412920 [TBL] [Abstract][Full Text] [Related]
15. Excitatory and depressant effects of delta 9-tetrahydrocannabinol and cannabidiol on cortical evoked responses in the conscious rat. Turkanis SA; Karler R Psychopharmacology (Berl); 1981; 75(3):294-8. PubMed ID: 6275447 [TBL] [Abstract][Full Text] [Related]
16. Interactions between cannabidiol and Δ Todd SM; Zhou C; Clarke DJ; Chohan TW; Bahceci D; Arnold JC Eur Neuropsychopharmacol; 2017 Feb; 27(2):132-145. PubMed ID: 28043732 [TBL] [Abstract][Full Text] [Related]
17. delta 9-Tetrahydrocannabinol and cannabidiol: dose-dependent effects on evoked potentials in the hippocampal slice. Kujtan PW; Carlen PL; Kapur BM Can J Physiol Pharmacol; 1983 Apr; 61(4):420-6. PubMed ID: 6305469 [TBL] [Abstract][Full Text] [Related]
18. Effects on variable-interval performance in rats of delta 9-tetrahydrocannabinol and cannabidiol, separately and in combination. Zuardi AW; Karniol IG Braz J Med Biol Res; 1983 Jul; 16(2):141-6. PubMed ID: 6317104 [TBL] [Abstract][Full Text] [Related]
19. Rabbit behavioral model of marijuana psychoactivity in humans. Consroe P; Fish BS Med Hypotheses; 1981 Aug; 7(8):1079-90. PubMed ID: 6270517 [TBL] [Abstract][Full Text] [Related]
20. Effects of delta-9-tetrahydrocannabinol, 11-hydroxy-delta-9-tetrahydrocannabinol and cannabidiol on neuromuscular transmission in the frog. Turkanis SA; Karler R Neuropharmacology; 1986 Nov; 25(11):1273-8. PubMed ID: 3025765 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]